About the journal
Sclerosis is an open-access journal published by MDPI AG in Switzerland, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 1,000 CHF. Declared review time at DOAJ: 6 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- MDPI AG
- ISSN
- 2813-3064
- Country
- Switzerland
- Languages
- english
- Access
- Open access
- Declared publication charge
- 1,000 CHF
- Articles in DOAJ
- 57
- Declared review time
- 6 weeks
- Declared peer-review model
- other
- Official website
- https://www.mdpi.com/journal/sclerosis
Index listings
- DOAJ · 2025-05-12
- Indexing
- DOAJ
- APC
- 1,000 CHF
- Declared review time (DOAJ)
- 6 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
57
Most recent article
4 months ago
Average review time (journal-declared via DOAJ)
6weeks
Works in OpenAlex
96
Last recorded publication year
2026
h-index
6
i10-index
2
From OpenAlex open data (CC0).
Editorial & policy12
- Last DOAJ review date
- 2025-05-12
- Added to DOAJ
- 2025-05-12
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSS
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSS
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 100%
- ORCID iDs in current deposits
- 96%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity1
- Source type
- journal
Classification4
Subjects (DOAJ)
LCC codes
Subject areas
- Multiple Sclerosis Research Studies
- Multiple Sclerosis Research Studies
- Multiple Sclerosis Research Studies
- Systemic Sclerosis and Related Diseases
- Systemic Sclerosis and Related Diseases
- Systemic Sclerosis and Related Diseases
- Amyotrophic Lateral Sclerosis Research
- Amyotrophic Lateral Sclerosis Research
Show all subjects (75)
- Pulmonary Hypertension Research and Treatments
- Connective tissue disorders research
- Amyotrophic Lateral Sclerosis Research
- Peripheral Neuropathies and Disorders
- Peripheral Neuropathies and Disorders
- Peripheral Neuropathies and Disorders
- Balance, Gait, and Falls Prevention
- Inflammatory Myopathies and Dermatomyositis
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Psoriasis: Treatment and Pathogenesis
- Inflammatory Myopathies and Dermatomyositis
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Stroke Rehabilitation and Recovery
- Connective Tissue Growth Factor Research
- Chronic Kidney Disease and Diabetes
- Connective Tissue Growth Factor Research
- Polyomavirus and related diseases
- Dementia and Cognitive Impairment Research
- Systemic Lupus Erythematosus Research
- Fibromyalgia and Chronic Fatigue Syndrome Research
- Long-Term Effects of COVID-19
- Effects of Vibration on Health
- Balance, Gait, and Falls Prevention
- Renal Diseases and Glomerulopathies
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Effects of Vibration on Health
- Long-Term Effects of COVID-19
- Fibromyalgia and Chronic Fatigue Syndrome Research
- Systemic Lupus Erythematosus Research
- Autoimmune Neurological Disorders and Treatments
- Balance, Gait, and Falls Prevention
- Chronic Kidney Disease and Diabetes
- Skin Diseases and Diabetes
- Autoimmune Neurological Disorders and Treatments
- Renal Diseases and Glomerulopathies
- Chronic Kidney Disease and Diabetes
- Autoimmune Neurological Disorders and Treatments
- Neuroinflammation and Neurodegeneration Mechanisms
- Neuroinflammation and Neurodegeneration Mechanisms
- Renal Diseases and Glomerulopathies
- Cancer-related cognitive impairment studies
- Chronic Lymphocytic Leukemia Research
- Neurological disorders and treatments
- Systemic Lupus Erythematosus Research
- Nutritional Studies and Diet
- Cancer survivorship and care
- Cancer Immunotherapy and Biomarkers
- Hereditary Neurological Disorders
- Mindfulness and Compassion Interventions
- Neurological diseases and metabolism
- Medical Practices and Rehabilitation
- Neurological diseases and metabolism
- Skin Diseases and Diabetes
- MicroRNA in disease regulation
- Olfactory and Sensory Function Studies
- Genetic Neurodegenerative Diseases
- Stroke Rehabilitation and Recovery
- Genetic Neurodegenerative Diseases
- COVID-19 and Mental Health
- Dementia and Cognitive Impairment Research
- Botulinum Toxin and Related Neurological Disorders
- Mast cells and histamine
- Stroke Rehabilitation and Recovery
- Dementia and Cognitive Impairment Research
- Olfactory and Sensory Function Studies
- Botulinum Toxin and Related Neurological Disorders
- COVID-19 and Mental Health
Keywords (DOAJ)
- sclerosis
- atherosclerosis
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ